The CD155/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer
The CD155/TIGIT axis can be co-opted during immune evasion in chronic viral infections and cancer. Pancreatic adenocarcinoma (PDAC) is a highly lethal malignancy, and immune-based strategies to combat this disease have been largely unsuccessful to date. We corroborate prior reports that a substantia...
Main Authors: | Freed-Pastor, William A, Lambert, Laurens J, Ely, Zackery A, Pattada, Nimisha B, Bhutkar, Arjun, Eng, George, Mercer, Kim L, Garcia, Ana P, Lin, Lin, Rideout, William M, Hwang, William L, Schenkel, Jason M, Jaeger, Alex M, Bronson, Roderick T, Westcott, Peter MK, Hether, Tyler D, Divakar, Prajan, Reeves, Jason W, Deshpande, Vikram, Delorey, Toni, Phillips, Devan, Yilmaz, Omer H, Regev, Aviv, Jacks, Tyler |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Language: | English |
Published: |
Elsevier BV
2022
|
Online Access: | https://hdl.handle.net/1721.1/146821 |
Similar Items
-
CRISPR-mediated modeling and functional validation of candidate tumor suppressor genes in small cell lung cancer
by: Ng, Sheng Rong, et al.
Published: (2020) -
Combination TIGIT/PD-1 blockade enhances the efficacy of neoantigen vaccines in a model of pancreatic cancer
by: Hui Peng, et al.
Published: (2022-12-01) -
MHC-II neoantigens shape tumour immunity and response to immunotherapy
by: Luoma, Adrienne M., et al.
Published: (2020) -
931 Augmenting antigen presentation to improve CD8+ and CD4+ T cell responses in lung cancer
by: Jason Schenkel, et al.
Published: (2023-11-01) -
Inducible de novo expression of neoantigens in tumor cells and mice
by: Damo, Martina, et al.
Published: (2022)